Where does Nicholas Haft work?

Nicholas Haft is Managing Director at OMX Ventures.

What does Nicholas Haft invest in?

Nicholas Haft invests in Biotech.

What check size does Nicholas Haft write?

Nicholas Haft typically writes checks of $500K – $15M.

Where did Nicholas Haft go to school?

Nicholas Haft studied at The Wharton School.

Nicholas Haft

Investor

Managing Director at OMX Ventures

New York, New York

Writes $500K – $15M checks · typically $7.8M

Find your path to Nicholas

446 people in our graph share verified history with Nicholas — schools, employers, funds. One of them is your warm intro.

Rebecca JamesunlockedNicholas: together at The Wharton School (2008–2011)

×11Nicholas: together at The Wharton School

About

Nick Haft is an investor at OMX Ventures. He previously served as the sole managing partner at Arcos Ventures, where he deployed more than $80M across 20+ bio-related companies, and he co-founded Delix Therapeutics, a startup developing therapies for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.

Contact· self-published, not guessed

n•••@omx.vcreveal

Invests in

Biotech

Experience

OMX VenturesManaging Directorcurrent2020 — presentNew York, New York, United States
Delix TherapeuticsCo-Foundercurrent2019 — presentNew York, United States
Arcos VenturesManaging Director2014 — 2020New York, United States

Investments

Investor

10X GenomicsCompass PathwaysFinch TherapeuticsGinkgo BioworksImagenPendulum Therapeutics

Per the firm's website.

Colleagues at OMX Ventures

Anthony Craig Asher

General Partner at OMX Ventures

Craig Asher

Managing Director at OMX Ventures

Daniel Fero

Managing Director at OMX Ventures

Fred Sweeney

Venture Partner at OMX Ventures

John Nawrocki

Chief Financial Officer at OMX Ventures

Natasha Azar

Vice President Investor Relations at OMX Ventures

Paul Conley

Chairman & CEO at GENERAL INCEPTION

Swetha Murali

Vice President at OMX Ventures

Network1

Daniel Fero

Managing Director at OMX Ventures

Investors connected to Nicholas in public investor directories — a warm-intro map.

Frequently asked questions

Who is Nicholas Haft?: Nick Haft is an investor at OMX Ventures. He previously served as the sole managing partner at Arcos Ventures, where he deployed more than $80M across 20+ bio-related companies, and he co-founded Delix Therapeutics, a startup developing therapies for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.
Where does Nicholas Haft work?: Nicholas Haft is Managing Director at OMX Ventures.
What does Nicholas Haft invest in?: Nicholas Haft invests in Biotech.
What check size does Nicholas Haft write?: Nicholas Haft typically writes checks of $500K – $15M.
What companies has Nicholas Haft invested in?: Investments tracked here include 10X Genomics, Compass Pathways, Finch Therapeutics, Ginkgo Bioworks, Imagen, Pendulum Therapeutics.
Where did Nicholas Haft go to school?: Nicholas Haft studied at The Wharton School.